GlaxoSmithKline FDA advisory recommendation

A global healthcare company that develops, manufactures and markets pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products.  I have a holding in my income portfolio (epic code: GSK). 

Following on from their 5 September announcement on MAGE-A3 cancer immunotherapeutic failure to meet first co-primary endpoint in Phase III melanoma clinical trial, Glaxo announced today that the US FDA Advisory Committee recommended approval of umeclidinium/vilanterol for the treatment of chronic obstructive pulmonary disease.

This drug is jointly developed by Glaxo and Theravance and if approved, will be the first, once-daily dual bronchodilator available in the US.